Last month’s performance of -0.13% for Aerie Pharmaceuticals Inc. (AERI) is certainly impressive


Aerie Pharmaceuticals Inc. (NASDAQ: AERI) kicked off on September 22, 2022, at the price of $15.15, down -0.07% from the previous trading day. During the day, the shares moved up to $15.18 and dropped to $15.14 before settling in for the closing price of $15.15. Over the past 52 weeks, AERI has traded in a range of $4.81-$15.37.

Top 5 Tech Stocks Every Investor Should Buy Right Now

While finding excellent stocks with the potential for gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Tech Stocks Every Investor Should Buy Right Now", we have identified five tech stocks we believe could appreciate.

Sign up here to get your free report now.


While this was happening, its average annual earnings per share was recorded 59.50%. With a float of $48.51 million, this company’s outstanding shares have now reached $49.41 million.

The extent of productivity of a business whose workforce counts for 376 workers is very important to gauge. In terms of profitability, gross margin is +86.17, operating margin of -23.88, and the pretax margin is -38.23.

Aerie Pharmaceuticals Inc. (AERI) Latest Financial update

In the latest quarterly report, which was put into the public domain on 3/30/2022, the organization reported -$0.66 earnings per share (EPS), lower than consensus estimate (set at -$0.65) by -$0.01. This company achieved a net margin of -38.54 while generating a return on equity of -2,255.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.52 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 59.50% per share during the next fiscal year.

Aerie Pharmaceuticals Inc. (NASDAQ: AERI) Trading Performance Indicators

Take a look at Aerie Pharmaceuticals Inc.’s (AERI) current performance indicators. Last quarter, stock had a quick ratio of 2.20. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.63.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.04, a number that is poised to hit -0.44 in the next quarter and is forecasted to reach -1.01 in one year’s time.

Technical Analysis of Aerie Pharmaceuticals Inc. (AERI)

The latest stats from [Aerie Pharmaceuticals Inc., AERI] show that its last 5-days average volume of 0.83 million was inferior to 1.03 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 28.10%. Additionally, its Average True Range was 0.27.

During the past 100 days, Aerie Pharmaceuticals Inc.’s (AERI) raw stochastic average was set at 97.82%, which indicates a significant increase from 22.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 4.31% in the past 14 days, which was lower than the 94.65% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $11.73, while its 200-day Moving Average is $8.58. Now, the first resistance to watch is $15.17. This is followed by the second major resistance level at $15.19. The third major resistance level sits at $15.21. If the price goes on to break the first support level at $15.13, it is likely to go to the next support level at $15.11. The third support level lies at $15.09 if the price breaches the second support level.

Aerie Pharmaceuticals Inc. (NASDAQ: AERI) Key Stats

The company with the Market Capitalisation of 752.16 million has total of 49,360K Shares Outstanding. Its annual sales at the moment are 194,130 K in contrast with the sum of -74,810 K annual income. Company’s last quarter sales were recorded 33,310 K and last quarter income was -19,370 K.


Please enter your comment!
Please enter your name here